These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 19338993

  • 1. High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms.
    Di Fede G, Mansueto P, Pepe I, Rini GB, Carmina E.
    Fertil Steril; 2010 Jun; 94(1):194-7. PubMed ID: 19338993
    [Abstract] [Full Text] [Related]

  • 2. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
    Kelekci KH, Kelekci S, Incki K, Ozdemir O, Yilmaz B.
    Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
    [Abstract] [Full Text] [Related]

  • 3. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 4. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
    Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA.
    J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
    [Abstract] [Full Text] [Related]

  • 5. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M, Azziz R, Beires J, Pignatelli D.
    Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
    [Abstract] [Full Text] [Related]

  • 6. What every physician should know about polycystic ovary syndrome.
    Rosenfield RL.
    Dermatol Ther; 2008 Jul; 21(5):354-61. PubMed ID: 18844713
    [Abstract] [Full Text] [Related]

  • 7. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 8. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH.
    Am J Epidemiol; 2008 Aug 01; 168(3):321-8. PubMed ID: 18550559
    [Abstract] [Full Text] [Related]

  • 9. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
    Shi Y, Gao X, Sun X, Zhang P, Chen Z.
    Fertil Steril; 2008 Oct 01; 90(4):1139-43. PubMed ID: 17889857
    [Abstract] [Full Text] [Related]

  • 10. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.
    Ansarin H, Aziz-Jalali MH, Rasi A, Soltani-Arabshahi R.
    Arch Iran Med; 2007 Jan 01; 10(1):7-13. PubMed ID: 17198446
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups.
    Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R.
    Fertil Steril; 2005 Jun 01; 83(6):1717-23. PubMed ID: 15950641
    [Abstract] [Full Text] [Related]

  • 12. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis.
    Mor E, Zograbyan A, Saadat P, Bayrak A, Tourgeman DE, Zhang C, Stanczyk FZ, Paulson RJ.
    Am J Obstet Gynecol; 2004 Jun 01; 190(6):1654-60. PubMed ID: 15284763
    [Abstract] [Full Text] [Related]

  • 13. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI.
    Fertil Steril; 2009 Dec 01; 92(6):1960-5. PubMed ID: 18980763
    [Abstract] [Full Text] [Related]

  • 14. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study.
    Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibañez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, Pugeat M, Rohmer V, Speiser PW, Witchel SF.
    Am J Obstet Gynecol; 2000 Dec 01; 183(6):1468-74. PubMed ID: 11120512
    [Abstract] [Full Text] [Related]

  • 15. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 01; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 16. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R, Hickey M, Franks S.
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct 01; 18(5):671-83. PubMed ID: 15380140
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group.
    Farah L, Lazenby AJ, Boots LR, Azziz R.
    J Reprod Med; 1999 Oct 01; 44(10):870-4. PubMed ID: 10554748
    [Abstract] [Full Text] [Related]

  • 18. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
    Pignatelli D.
    Front Horm Res; 2013 Oct 01; 40():158-70. PubMed ID: 24002412
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B, Slopien R, Warenik-Szymankiewicz A.
    Eur J Obstet Gynecol Reprod Biol; 2007 May 01; 132(1):88-92. PubMed ID: 16979812
    [Abstract] [Full Text] [Related]

  • 20. The prevalence of androgen excess among patients with minimal unwanted hair growth.
    Souter I, Sanchez LA, Perez M, Bartolucci AA, Azziz R.
    Am J Obstet Gynecol; 2004 Dec 01; 191(6):1914-20. PubMed ID: 15592272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.